Apollo Endosurgery was incubated by PTV Sciences and received initial support through a seed grant from the University of Texas Medical Branch.
"Apollo's unique collaboration of world renowned therapeutic endoscopists and minimally invasive surgeons combined with their broad patent base presents a compelling investment opportunity," said Matt Crawford of PTV Sciences.
"Natural orifice surgery represents the future of minimally invasive surgery, and Apollo Endosurgery has an excellent foundation to build a franchise in this growing field," added Bruce Robertson of H.I.G. Ventures.
About Apollo Endosurgery, Inc.
Apollo has assembled the key intellectual property and thought leaders in the field of natural orifice surgery via a unique partnership with the Apollo Group. The Apollo Group is a rare example of academic collaboration that began in the late 1990s, pooling intellect from seven thought-leading gastroenterologists and surgeons, including Drs. Sydney Chung from the Chinese University of Hong Kong, Anthony Kalloo and Sergey Kantsevoy of Johns Hopkins University, Christopher Gostout from the Mayo Clinic, Robert Hawes and Peter Cotton from the Medical University of South Carolina, and Jay Pasricha, formerly of the University of Texas Medical Branch. Apollo Endosurgery Inc. has a worldwide license from the Apollo Group for a wide breadth of translumenal and endolumenal methods and devices.
About PTV Sciences II
PTV Sciences was founded on the principle of achieving lasting
financial success through the exploration of new frontiers. Our name and
symbol of the Pinto horse captures the legacy of the southwestern spirit
and dates back to the early successes of pioneers in oil and gas
exploration. We believe that opportunities to create new industries exist
in applied sciences and engineering, including biology, chemistry and
physics. PTV Sciences invests in companies
|SOURCE Apollo Endosurgery, Inc.|
Copyright©2007 PR Newswire.
All rights reserved